4569 — Kyorin Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapSuper Stock

Annual balance sheet for Kyorin Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	R2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Tanshin	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27,494	19,394	13,985	16,514	15,081
Net Total Accounts Receivable
Net Total Receivables	41,636	47,250	47,699	47,541	47,298
Total Inventory
Total Other Current Assets
Total Current Assets	116,376	119,030	119,240	136,134	135,142
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24,334	25,834	28,950	30,303	30,506
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	171,924	176,045	177,627	193,618	195,455
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32,182	34,983	45,491	35,111	29,368
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	47,417	50,584	46,892	57,333	53,030
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	124,507	125,461	130,735	136,285	142,425
Total Liabilities & Shareholders' Equity	171,924	176,045	177,627	193,618	195,455
Total Common Shares Outstanding